Daily non-political popular news in brief.
NYU researchers developing molecular delivery vehicles for genetic therapies
11-13-2006 · EurekAlert!Researchers at New York University are working to develop molecular delivery vehicles that can be used to transport nucleic acids into diverse cell types, which may lead to eventual applications in genetic therapies. Their work is described as part of the cover story in the November 13 issue of the American Chemical Society publication Chemical and Engineering News.
Read more »
Keywords: nyu, researchers, developing, molecular, delivery, vehicles, genetic, therapies, researcher, vehicle, therapy
« Previous | Next »
Similar news on "NYU researchers developing molecular delivery vehicles for genetic therapies":
- Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
08-13-2007 · EurekAlert!
Two new studies may lead to the development of more effective therapies for individuals with multiple myeloma, a common and incurable blood cell cancer. The research, published by Cell Press in the August issue of the journal Cancer Cell, provides new insight into the molecular mechanisms that underlie aberrant NF-κB activity in MM tumor cells and underscores the relevance of the signaling pathway as a target for MM therapy.
Similar news · Read more »
- Genetic predisposition increases childhood asthma risk
08-20-2007 · EurekAlert!
Children who carry variations in specific genes that metabolize vehicle emissions are more susceptible to developing asthma, particularly if they live near major roadways, a study led by researchers at the University of Southern California suggests.
Similar news · Read more »
- Pellets of power designed to deliver hydrogen for tomorrow's vehicles
08-21-2007 · EurekAlert!
Hydrogen may prove to be the fuel of the future in powering the efficient, eco-friendly fuel cell vehicles of tomorrow. Developing a method to safely store, dispense and easily "refuel" the vehicle's storage material with hydrogen has baffled researchers for years. However, a new and attractive storage medium being developed by Pacific Northwest National Laboratory scientists may provide the"power of pellets" to fuel future transportation needs.
Similar news · Read more »
- New technique reveals subtle force-induced changes in biomolecule's conformation
10-15-2007 · EurekAlert!
Scientists studying biological systems at the molecular level now have a new hybrid technique to probe the dynamics of the Holliday junction. The Holliday junction is a four-stranded DNA structure that forms during a process known as homologous recombination, which occurs when damaged DNA is repaired. Understanding how DNA repairs itself is an essential step in ultimately developing therapies for genetic disorders.
Similar news · Read more »
- First report that apoptotic and anti-angiogenic therapies work better together than alone
11-10-2006 · EurekAlert!
American researchers have found that giving a combination of imantanib and a drug that induces cell death was better at inhibiting the growth of Ewing's sarcoma in mice than either therapy on its own, according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague on Friday.
Similar news · Read more »
- Novel test identifies leukemia patients likely to respond to new therapy
02-20-2007 · EurekAlert!
Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.
Similar news · Read more »
- Genes and biomarkers that allow doctors to choose the right therapy for the right patient
04-17-2007 · EurekAlert!
Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers. Now, researchers have the tools and the knowledge to help predict how individuals will respond to cancer therapies, enabling them to create more effective therapies for individual cancers -- personalized medicine.
Similar news · Read more »
- A molecular switch is linked to a common breast cancer
11-08-2007 · EurekAlert!
Researchers have discovered that a molecular switch in the protein-making machinery of cells is linked to one of the most common forms of lethal breast cancer worldwide. The discovery by researchers at NYU School of Medicine could lead to new therapies for the cancer, called locally advanced breast cancer.
Similar news · Read more »
- Study finds limited options for backup HIV treatment in some developing countries
01-08-2007 · EurekAlert!
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. Since catching treatment failure early is key to preventing further resistance, this research, published in the February 1 issue of Clinical Infectious Diseases also argues for greater access in the developing world to tests that detect when the amount of virus in a patient's blood is increasing.
Similar news · Read more »
- Novel test identifies lymphoma patients likely to respond to new therapy
02-20-2007 · EurekAlert!
Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.
Similar news · Read more »
